Tag Archives: Ariad

TALKING WRITTEN DESCRIPTION REQUIREMENT BLUES – ARIAD WOBBLES

On October 5, 2009, Ariad filed a 60 page brief (not counting attached appendices) with the Federal Circuit in support of its appeal in Ariad v. Lilly. (Attached below.) As you will recall from my post of August 24th, the … Continue reading

Posted in Written Description Requirements (WDR) | Tagged , , , , , , , , | Leave a comment

Federal Circuit Grants Ariad’s Petition for Rehearing En Banc to Settle WDR Hash.

At long last, the Federal Circuit will specifically address the questions of (a) whether or not section 112 contains a written description requirement separate from the enablement requirement and, if it does (b) what is its scope and purpose. Hopefully, … Continue reading

Posted in Written Description Requirements (WDR) | Tagged , , , , | 1 Comment

NATURE/BIOTECHNOLOGY SUMMARIZES ARIAD DECISION

A recent article by Ken Garber in Nature/Biotechnology, 27, 494 (June 2009) summarizes the recent Federal Circuit decision invalidating the claims-in-suit in Ariad v. Lilly for failure to meet the WDR. (See my post of April 13, 2009 “Federal Circuit … Continue reading

Posted in Written Description Requirements (WDR) | Tagged , , , , , , , , , , , , | Leave a comment

IN SEARCH OF CHAKRABARTY, “NATURAL PHENOMENA” AND WHERE BILSKI WENT BAD, WITH A GLANCE BACK AT ARIAD.

I was finishing up my recent comment on the reexamination proceedings involving the Baltimore et al. patent, when a fragment of one of the Office Actions caught my eye and stuck in my mind. The Examiner is trying to explain … Continue reading

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , | Leave a comment